5-(tert-Butyl) 4-methyl (1aR,4R,6aR,7aR)-octahydro-5H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4,5-dicarboxylate

Catalog No. :
ACFDNH637
CAS No. :
1452400-46-2
Molecular Formula :
C15H24N2O4
Molecular Weight :
296.37

IUPAC Name:5-(tert-butyl) 4-methyl (1aR,4R,6aR,7aR)-octahydro-5H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4,5-dicarboxylate

5-(tert-Butyl) 4-methyl (1aR,4R,6aR,7aR)-octahydro-5H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4,5-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(tert-Butyl) 4-methyl (1aR,4R,6aR,7aR)-octahydro-5H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4,5-dicarboxylate
IUPAC Name5-(tert-butyl) 4-methyl (1aR,4R,6aR,7aR)-octahydro-5H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4,5-dicarboxylate
MDL No.0
Molecular FormulaC15H24N2O4
Molecular Weight296.37
SMILESC(OC)(=O)[C@H]1CN2[C@]3([C@](C3)(C[C@@]2(CN1C(OC(C)(C)C)=O)[H])[H])[H]
InChI KeyAYYGDVWGZDSMBI-IRCOFANPSA-N
Synonym5H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4,5-dicarboxylic acid, octahydro-, 5-(1,1-dimethylethyl) 4-methyl ester, (1aR,4R,6aR,7aR)-;Methyl (1aR,4R,6aR,7aR)-5-Boc-octahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-4-carboxylate
CAS No.1452400-46-2

Synthetic Route by SureRoute

1. ACFDNH637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFDNH637 route product structure diagram
    ACFDNH6371452400-46-2
Inquiry

2. ACFDNH637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFDNH637 route product structure diagram
    ACFDNH6371452400-46-2
Inquiry

Comments (0)